# Insulin-like growth factor 1 receptor (IGF1R)-dependent signaling regulates blastocyst formation during early embryonic development

**Authors:** Chi-Hun Park, Young-Hee Jeoung, JiTao Wang, Bhanu P. Telugu

PMC · DOI: 10.3389/fcell.2026.1783082 · Frontiers in Cell and Developmental Biology · 2026-02-19

## TL;DR

This study shows that the IGF1R receptor is not needed for early cell fate decisions in embryos but is important for proper blastocyst growth and survival.

## Contribution

The study reveals that IGF1R signaling is essential for blastocyst development and viability but not for lineage segregation in early embryos.

## Key findings

- Embryos lacking IGF1R formed blastocysts but showed delayed development and increased apoptosis.
- Exogenous IGF-1 failed to rescue IGF1R-deficient embryos and worsened apoptosis when signaling was blocked.
- IGF1R signaling is crucial for blastocyst growth dynamics and embryonic viability but not for lineage segregation.

## Abstract

Insulin-like growth factor 1 (IGF1) signaling is a conserved regulator of embryonic growth and survival. However, the specific role of IGF1 signaling mediated by its cognate receptor IGF1R during mammalian preimplantation development remains unclear and unexplored. In this study, we employed both genetic ablation using cytidine deaminase base editors and pharmacological inhibition to assess the role of IGF1R in porcine early embryonic development. Embryos lacking IGF1R advanced through early cleavage divisions and progressed to blastocyst formation; however, they displayed delayed blastocyst development and significantly increased apoptosis. Lineage segregation was largely unperturbed. Exogenous IGF-1 supplementation did not ameliorate developmental impairments in IGF1R-knockout embryos and instead exacerbated apoptotic responses when receptor signaling was compromised. Collectively, these results establish that IGF1R signaling is dispensable for cell fate specification but is crucial for regulating blastocyst growth dynamics and embryonic viability.

## Linked entities

- **Genes:** IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480]
- **Proteins:** IGF1 (insulin like growth factor 1), IGF1R (insulin like growth factor 1 receptor)

## Full-text entities

- **Genes:** SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, IGF1 (Insulin-like growth factor 1 level) [NCBI Gene 101055342], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, HSPG2 (heparan sulfate proteoglycan 2) [NCBI Gene 3339] {aka HSPG, PLC, PRCAN, SJA, SJS, SJS1}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, Sqstm1 (sequestosome 1) [NCBI Gene 18412] {aka A170, OSF-6, Osi, STAP, STONE14, p62}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, CS (citrate synthase) [NCBI Gene 1431], TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, GATA6 (GATA binding protein 6) [NCBI Gene 2627], IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 397350], CDA (cytidine deaminase) [NCBI Gene 978] {aka CDD}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 100126861] {aka Akt, PKB}, ALB (albumin) [NCBI Gene 280717], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, Insr (insulin receptor) [NCBI Gene 16337] {aka 4932439J01Rik, CD220, D630014A15Rik, IR, IR-A, IR-B}, CTNNB1 (catenin beta 1) [NCBI Gene 397657], CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321] {aka PPH7, VUR3}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, MYOZ3 (myozenin 3) [NCBI Gene 91977] {aka CS-3, CS3, FATZ-3, FRP3}, IGF1 (insulin like growth factor 1) [NCBI Gene 397491] {aka IGF-1, IGF-I, Npt2B}, Igf1r (insulin-like growth factor I receptor) [NCBI Gene 16001] {aka A330103N21Rik, CD221, D930020L01, IGF-1R, hyft}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, IGF2R (insulin like growth factor 2 receptor) [NCBI Gene 3482] {aka CD222, CI-M6PR, CIMPR, M6P-R, M6P/IGF2R, MPR 300}, CDKN1B (cyclin dependent kinase inhibitor 1B) [NCBI Gene 1027] {aka CDKN4, KIP1, MEN1B, MEN4, P27KIP1}, SNORA62 (small nucleolar RNA, H/ACA box 62) [NCBI Gene 6044] {aka E2, E2-1, RNE2, RNU108}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}
- **Diseases:** growth restriction (MESH:D005317), SCNT (MESH:D013001), PTC (MESH:D000077273), PFF (MESH:D005315), developmental defects (MESH:D000094602), neonatal lethality (MESH:C537510), developmental impairment (MESH:D007805), developmental delay (MESH:D002658)
- **Chemicals:** O2 (MESH:D010100), Triton X-100 (MESH:D017830), DPBS (MESH:C012939), NP-40 (MESH:C010615), N2 (MESH:D009584), glycogen (MESH:D006003), cytosine (MESH:D003596), ethanol (MESH:D000431), polyvinylpyrrolidone (MESH:D011205), BE4 (-), thymidine (MESH:D013936), paraformaldehyde (MESH:C003043), CS (MESH:D002586), CO2 (MESH:D002245), 4,6-diamidino-2-phenylindole (MESH:C007293), glucose (MESH:D005947), 6-dimethylaminopurine (MESH:C001020), PBS (MESH:D007854), Scriptaid (MESH:C410733), cytochalasin B. (MESH:D003571)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Bos taurus (bovine, species) [taxon 9913]
- **Cell lines:** E2 — Mus musculus (Mouse), Carcinoma of the mouse prostate gland, Cancer cell line (CVCL_S003)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960595/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960595/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960595/full.md

---
Source: https://tomesphere.com/paper/PMC12960595